Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations
- 1 December 1995
- journal article
- conference paper
- Published by Elsevier in Behavioural Brain Research
- Vol. 73 (1-2) , 103-107
- https://doi.org/10.1016/0166-4328(96)00078-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)The British Journal of Psychiatry, 1994
- Increasing Use of “Ecstasy“ (MDMA) and other Hallucinogens on a College CampusJournal of American College Health, 1994
- Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")The Lancet, 1992
- Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imagingEuropean Journal of Radiology, 1992
- Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use: Effects on Mood and Neuropsychological Function?The American Journal of Drug and Alcohol Abuse, 1992
- New Age Seekers: MDMA Use as an Adjunct to Spiritual PursuitJournal of Psychoactive Drugs, 1991
- Neuroendocrine Pharmacology of Serotonergic (5-HT) NeuronsAnnual Review of Pharmacology and Toxicology, 1991
- Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)Journal of Neurochemistry, 1990
- Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate CampusNew England Journal of Medicine, 1987
- Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve TerminalsScience, 1985